![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab in it for the long haul in psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1225, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab REVEALed as the CHAMPION in psoriasis
Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: Psoriasis: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1378, 2011-01 ,pp. :